Researchers at the Mayo Clinic have now confirmed that yet, another body system retains gadolinium, the contrast agent used in MRI. In a new study published in the journal, Radiology, 68 patients at the Mayo Clinic had a gadolinium-based contrasted MRI followed by a lumbar puncture. Gadolinium was detected in ALL 68 samples of cerebrospinal fluid (CSF). It was previously believed that gadolinium accumulated only in people with impaired kidney function, however, new studies including this one, have shown that even patients with normal kidney function can be affected. It was also believed that only people with disruption of the blood-brain barrier (BBB) could retain gadolinium, but this study revealed the presence of gadolinium in the CSF even in patients with an intact BBB. The authors of the study stated that this finding has “substantial clinical and pharmacologic implications”. To read more, visit: https://pubs.rsna.org/doi/abs/10.1148/radiol.2018171105 Please join the growing list of advocates and sign our petition so we can help promote the development of safer alternatives and effective treatments to remove gadolinium from patients affected by it.